Navigation Links
Measuring waist circumference would improve the detection of children and adolescents with cardiometabolic risk
Date:1/28/2014

Barcelona, 28th January 2014. A study led by researchers from IMIM (Hospital del Mar Medical Research Institute) and published in the journal Plos One concludes that including waist circumference measurements in clinical practice, together with the traditional height and weight measurements, would make it easier to detect children and adolescents with cardiometabolic risk, i.e. those with a higher predisposition to suffer from arteriosclerosis or type 2 diabetes. This study is the first of its kind in Spain on abdominal obesity in children and adolescents, one of the most important risk factors associated to this disorder, which has increased in recent years.

Researchers analysed data from 1521 Spanish children and adolescents aged 6 to 17 that participated in the ENKID study on nutrition and dietary habits and measured the proportion of abdominal obesity both in children and adolescents with a normal weight and those who were overweight. To do this they measured the waist circumference and height, known as the waist-to-height ratio, an indicator that is totally independent from age and gender, which estimates that abdominal obesity exists when the result is equal or higher than 0.5.

According to Helmut Schrder, a researcher from the research group on cardiovascular risk and nutrition at IMIM and also a member of the CIBER on Epidemiology and Public Health, "In Spain, 21.3% of children aged 6 to 11 and 14.3% of adolescents aged 12 to 17 have abdominal obesity. From the total of Spanish children with a normal weight or overweight, 7.5% of those with a normal weight had abdominal obesity, while from those overweight, 49.2% have abdominal obesity. None of them would have been identified using the traditional screening methods. The same is true for adolescents, where 1.8% have a normal weight and 44.1% are overweight and wouldn't have been detected either."

According to Llus Serra-Majem, a researcher from the Department of Clinical Science at the University of Las Palmas de Gran Canaria and a member of the CIBER on the Physiopathology of Obesity and nutrition, contrary to what may be thought, "there are people, both adults and young people, whose weight is totally normal and yet have abdominal obesity and vice-versa; people who are overweight and with fat distributed in all their body who, therefore face a lower cardiometabolic risk". Abdominal fat is important when suffering from cardiovascular or metabolic diseases at an early age and it has been seen that, when using traditional measurements, a number of children and adolescents with this cardiometabolic risk go undetected.

The epidemic of child obesity is one of the biggest challenges for health policies. Based on the results of this study, researchers believe that it is necessary to include waist circumference measurements in routine clinical practice. It is a measurement that is easy to take, with no additional costs, and would only take doctors a few minutes. This would allow a greater control of this risk group that currently goes undetected and would allow preventing future cardiometabolic events at an early age or later on in life.


'/>"/>
Contact: Marta Calsina
mcalsina@imim.es
34-933-160-680
IMIM (Hospital del Mar Medical Research Institute)
Source:Eurekalert

Related medicine news :

1. Measuring the uncertainties of pandemic influenza
2. Measuring glucose without needle pricks
3. Measuring molecules with the naked eye
4. Measuring metabolism can predict Alzheimers progress with 90 percent accuracy
5. ACP recommends Stage 3 Meaningful Use focus on measuring improvements in health outcomes
6. Measuring the consequence of forest fires on public health
7. The Holistic Sanctuary Conducts Emergency Poll in the Aftermath of the Death of Cory Monteith: Measuring the Effectiveness of Conventional Drug Rehab Centers
8. Stay Heart Healthy by Measuring LDL Particle Size and Save 10% with Request A Test
9. Colorectal surgeons develop a novel tool for measuring quality and outcomes
10. Lumosity presents new data on measuring cognitive training improvements
11. Long-term testosterone treatment for men results in reduced weight and waist size
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Guruji Mahendra Kumar Trivedi is ... 11th, 2016 in honor of his birthday on February 10th. During this time, ... Trivedi is known by over 250,000 people from over 40 different countries as an ...
(Date:2/8/2016)... ... February 08, 2016 , ... According to research by the ... dental technicians to be certified or obtain continuing education. To increase patient awareness ... In Your Mouth?” campaign to inform dentists and patients about the possible lack ...
(Date:2/7/2016)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... February 07, ... ... women on Friday in recognition of National Wear Red Day. National Wear Red ... heart disease and stroke in women. Heart disease and stroke cause 1 in 3 ...
(Date:2/7/2016)... ... 2016 , ... Dr. Todd Hobgood , certificated in ... surgical expertise. Technically known as deoxycholic acid or previously as ATX-101, Kybella® ... for reduction of fat below the chin (aka the “double chin”). Medication side ...
(Date:2/6/2016)... ... 2016 , ... US Sports Camps is proud to sponsor the Bay Area ... top non-profit leaders, ultimate organizations, and coaches from around the US. The theme for ... Program Director of Youth and Education, describes this year YUCC as “an important conversation ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016 ... the addition of the "Label-Free Detection ... Forecasts to 2020" report to their ... announced the addition of the "Label-Free ... Global Forecasts to 2020" report to ...
(Date:2/8/2016)... , Feb. 8, 2016  Unilife Corporation ("Unilife" or "Company") ... of injectable drug delivery systems, today announced that it will ... ended December 31, 2015 after market close on February 9, ... conference call to discuss these financial results.    ... --> About Unilife Corporation ...
(Date:2/8/2016)... 8, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... announced that the U.S. Food and Drug Administration ... (IND) application for SB-318, a single treatment strategy ... Type I (MPS I). The SB-318 IND application ... a Phase 1/2 clinical study (SB-318-1502) designed to ...
Breaking Medicine Technology: